Effect of intranasal oxytocin on alcohol withdrawal syndrome: A randomized placebo-controlled double-blind clinical trial.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Effect of intranasal oxytocin on alcohol withdrawal syndrome: A randomized placebo-controlled double-blind clinical trial.
- Published In:
- Drug and alcohol dependence, 197, 95-101 (2019)
- Database ID:
- RPEP-04368
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-04368APA
Melby, Katrine; Gråwe, Rolf W; Aamo, Trond O; Salvesen, Øyvind; Spigset, Olav. (2019). Effect of intranasal oxytocin on alcohol withdrawal syndrome: A randomized placebo-controlled double-blind clinical trial.. Drug and alcohol dependence, 197, 95-101. https://doi.org/10.1016/j.drugalcdep.2019.01.003
MLA
Melby, Katrine, et al. "Effect of intranasal oxytocin on alcohol withdrawal syndrome: A randomized placebo-controlled double-blind clinical trial.." Drug and alcohol dependence, 2019. https://doi.org/10.1016/j.drugalcdep.2019.01.003
RethinkPeptides
RethinkPeptides Research Database. "Effect of intranasal oxytocin on alcohol withdrawal syndrome..." RPEP-04368. Retrieved from https://rethinkpeptides.com/research/melby-2019-effect-of-intranasal-oxytocin
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.